3 completed, 3 terminated, 1 withdrawn. 7 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 3, Terminated 3, Withdrawn 1 |
| Phase 1 | 2 | Completed 2 |
Follow figitumumab: new trials by email Literature Review of figitumumab trials Research Report on figitumumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Of Cisplatin (Or Carboplatin) And Etoposide With Or Without Figitumumab (CP-751,871) In Patients With Extensive-Stage Small Cell Lung Cancer figitumumab, Cisplatin (Or Carboplatin), Etoposide - Small Cell Lung Carcinoma | Phase 2 | Terminated | Pfizer | 9 | 2010-04-01 | 2013-02-25 |
| Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer CP-751,871, Docetaxel - Breast Cancer | Phase 2 | Withdrawn | Pfizer | 2009-04-01 | 2015-05-04 | |
| A Study of CP-751,871 in Patients With Recurrent Squamous Head and Neck Carcinoma CP-751,871 - Head and Neck Cancer | Phase 2 | Terminated | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 37 | 2009-01-01 | 2016-04-20 |
| Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors CP-751,871 - Ewing's Sarcoma Family of Tumors | Phase 1 / Phase 2 | Completed | Pfizer | 138 | 2008-03-01 | 2015-10-28 |
| Study Of CP-751,871 In Combination With Exemestane In Postmenopausal Women With Hormone Receptor Positive Advanced Breast Cancer CP-751,871, exemestane, Fulvestrant - Breast Neoplasms | Phase 2 | Terminated | Pfizer | 219 | 2007-02-01 | 2015-10-28 |
| Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC) CP-751,871, docetaxel, prednisone - Prostatic Neoplasms | Phase 2 | Completed | Pfizer | 204 | 2006-05-01 | 2013-04-11 |
| Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer CP-751,871, paclitaxel, carboplatin - Carcinoma, Non-Small-Cell Lung | Phase 1 / Phase 2 | Completed | Pfizer | 282 | 2005-02-01 | 2013-10-30 |
Breast Neoplasms (2) · Breast Diseases (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Squamous Cell (1) · Head and Neck Neoplasms (1) · Neoplasm Metastasis (1) · Prostatic Neoplasms (1) · Recurrence (1) · Small Cell Lung Carcinoma (1)
Pfizer (6) · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)
Canada (5) · United States (5) · Spain (4) · Italy (3) · United Kingdom (3) · Belgium (2) · Brazil (2) · Germany (2) · Argentina (1) · Australia (1) · Chile (1) · France (1) · Hungary (1) · Israel (1) · Netherlands (1)
Jean-Pascal Machiels, MDPhD (1)